S

Sarepta Therapeutics

D
SRPT
USD
-7.62
(-5.9531%)
Market Closed
93,076.00
Volume
1.9
EPS
-
Div Yield
160.507
P/E
11,480,199,286.92
Market Cap
Today
-5.9531%
1 Week
-4.453%
1 Month
2.242%
6 Months
-11.609%
12 Months
45.106%
Year To Date
24.940%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
I
IONS
-0.62
(-1.5869%)
USD
R
RGLS
0
(0%)
USD
B
BIIB
-0.32
(-0.1837%)
USD
REGN
REGN
8.505
(1.0417%)
USD
GILD
GILD
6.23
(6.7946%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
B
BLUE
-0.0729
(-16.2614%)
USD
C
CRSP
1.04
(2.0444%)
USD
E
EDIT
-0.11
(-3.3537%)
USD

Title:
Sarepta Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
Do you need help or have a question?
Contact Us